Biodefense-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Biodefense-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biodefense industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Biodefense 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biodefense worldwide and market share by regions, with company and product introduction, position in the Biodefense market
Market status and development trend of Biodefense by types and applications
Cost and profit status of Biodefense, and marketing status
Market growth drivers and challenges
The report segments the global Biodefense market as:
Global Biodefense Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Biodefense Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Global Biodefense Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Industry
Chemical
Global Biodefense Market: Manufacturers Segment Analysis (Company and Product introduction, Biodefense Sales Volume, Revenue, Price and Gross Margin):
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biodefense-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biodefense industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Biodefense 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biodefense worldwide and market share by regions, with company and product introduction, position in the Biodefense market
Market status and development trend of Biodefense by types and applications
Cost and profit status of Biodefense, and marketing status
Market growth drivers and challenges
The report segments the global Biodefense market as:
Global Biodefense Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Biodefense Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Global Biodefense Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Industry
Chemical
Global Biodefense Market: Manufacturers Segment Analysis (Company and Product introduction, Biodefense Sales Volume, Revenue, Price and Gross Margin):
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIODEFENSE
1.1 Definition of Biodefense in This Report
1.2 Commercial Types of Biodefense
1.2.1 Anthrax
1.2.2 Smallpox
1.2.3 Botulism
1.2.4 Radiation/Nuclear
1.3 Downstream Application of Biodefense
1.3.1 Industry
1.3.2 Chemical
1.4 Development History of Biodefense
1.5 Market Status and Trend of Biodefense 2013-2023
1.5.1 Global Biodefense Market Status and Trend 2013-2023
1.5.2 Regional Biodefense Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biodefense 2013-2017
2.2 Sales Market of Biodefense by Regions
2.2.1 Sales Volume of Biodefense by Regions
2.2.2 Sales Value of Biodefense by Regions
2.3 Production Market of Biodefense by Regions
2.4 Global Market Forecast of Biodefense 2018-2023
2.4.1 Global Market Forecast of Biodefense 2018-2023
2.4.2 Market Forecast of Biodefense by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Biodefense by Types
3.2 Sales Value of Biodefense by Types
3.3 Market Forecast of Biodefense by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Biodefense by Downstream Industry
4.2 Global Market Forecast of Biodefense by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Biodefense Market Status by Countries
5.1.1 North America Biodefense Sales by Countries (2013-2017)
5.1.2 North America Biodefense Revenue by Countries (2013-2017)
5.1.3 United States Biodefense Market Status (2013-2017)
5.1.4 Canada Biodefense Market Status (2013-2017)
5.1.5 Mexico Biodefense Market Status (2013-2017)
5.2 North America Biodefense Market Status by Manufacturers
5.3 North America Biodefense Market Status by Type (2013-2017)
5.3.1 North America Biodefense Sales by Type (2013-2017)
5.3.2 North America Biodefense Revenue by Type (2013-2017)
5.4 North America Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Biodefense Market Status by Countries
6.1.1 Europe Biodefense Sales by Countries (2013-2017)
6.1.2 Europe Biodefense Revenue by Countries (2013-2017)
6.1.3 Germany Biodefense Market Status (2013-2017)
6.1.4 UK Biodefense Market Status (2013-2017)
6.1.5 France Biodefense Market Status (2013-2017)
6.1.6 Italy Biodefense Market Status (2013-2017)
6.1.7 Russia Biodefense Market Status (2013-2017)
6.1.8 Spain Biodefense Market Status (2013-2017)
6.1.9 Benelux Biodefense Market Status (2013-2017)
6.2 Europe Biodefense Market Status by Manufacturers
6.3 Europe Biodefense Market Status by Type (2013-2017)
6.3.1 Europe Biodefense Sales by Type (2013-2017)
6.3.2 Europe Biodefense Revenue by Type (2013-2017)
6.4 Europe Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Biodefense Market Status by Countries
7.1.1 Asia Pacific Biodefense Sales by Countries (2013-2017)
7.1.2 Asia Pacific Biodefense Revenue by Countries (2013-2017)
7.1.3 China Biodefense Market Status (2013-2017)
7.1.4 Japan Biodefense Market Status (2013-2017)
7.1.5 India Biodefense Market Status (2013-2017)
7.1.6 Southeast Asia Biodefense Market Status (2013-2017)
7.1.7 Australia Biodefense Market Status (2013-2017)
7.2 Asia Pacific Biodefense Market Status by Manufacturers
7.3 Asia Pacific Biodefense Market Status by Type (2013-2017)
7.3.1 Asia Pacific Biodefense Sales by Type (2013-2017)
7.3.2 Asia Pacific Biodefense Revenue by Type (2013-2017)
7.4 Asia Pacific Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Biodefense Market Status by Countries
8.1.1 Latin America Biodefense Sales by Countries (2013-2017)
8.1.2 Latin America Biodefense Revenue by Countries (2013-2017)
8.1.3 Brazil Biodefense Market Status (2013-2017)
8.1.4 Argentina Biodefense Market Status (2013-2017)
8.1.5 Colombia Biodefense Market Status (2013-2017)
8.2 Latin America Biodefense Market Status by Manufacturers
8.3 Latin America Biodefense Market Status by Type (2013-2017)
8.3.1 Latin America Biodefense Sales by Type (2013-2017)
8.3.2 Latin America Biodefense Revenue by Type (2013-2017)
8.4 Latin America Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Biodefense Market Status by Countries
9.1.1 Middle East and Africa Biodefense Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Biodefense Revenue by Countries (2013-2017)
9.1.3 Middle East Biodefense Market Status (2013-2017)
9.1.4 Africa Biodefense Market Status (2013-2017)
9.2 Middle East and Africa Biodefense Market Status by Manufacturers
9.3 Middle East and Africa Biodefense Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Biodefense Sales by Type (2013-2017)
9.3.2 Middle East and Africa Biodefense Revenue by Type (2013-2017)
9.4 Middle East and Africa Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BIODEFENSE
10.1 Global Economy Situation and Trend Overview
10.2 Biodefense Downstream Industry Situation and Trend Overview
CHAPTER 11 BIODEFENSE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Biodefense by Major Manufacturers
11.2 Production Value of Biodefense by Major Manufacturers
11.3 Basic Information of Biodefense by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Biodefense Major Manufacturer
11.3.2 Employees and Revenue Level of Biodefense Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BIODEFENSE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Emergent Biosolutions
12.1.1 Company profile
12.1.2 Representative Biodefense Product
12.1.3 Biodefense Sales, Revenue, Price and Gross Margin of Emergent Biosolutions
12.2 Hytest
12.2.1 Company profile
12.2.2 Representative Biodefense Product
12.2.3 Biodefense Sales, Revenue, Price and Gross Margin of Hytest
12.3 GSK
12.3.1 Company profile
12.3.2 Representative Biodefense Product
12.3.3 Biodefense Sales, Revenue, Price and Gross Margin of GSK
12.4 Sanofi
12.4.1 Company profile
12.4.2 Representative Biodefense Product
12.4.3 Biodefense Sales, Revenue, Price and Gross Margin of Sanofi
12.5 PharmAthene
12.5.1 Company profile
12.5.2 Representative Biodefense Product
12.5.3 Biodefense Sales, Revenue, Price and Gross Margin of PharmAthene
12.6 Bavarian Nordic
12.6.1 Company profile
12.6.2 Representative Biodefense Product
12.6.3 Biodefense Sales, Revenue, Price and Gross Margin of Bavarian Nordic
12.7 SIGA Technologies
12.7.1 Company profile
12.7.2 Representative Biodefense Product
12.7.3 Biodefense Sales, Revenue, Price and Gross Margin of SIGA Technologies
12.8 Arbutus Biopharma
12.8.1 Company profile
12.8.2 Representative Biodefense Product
12.8.3 Biodefense Sales, Revenue, Price and Gross Margin of Arbutus Biopharma
12.9 DynPort Vaccine
12.9.1 Company profile
12.9.2 Representative Biodefense Product
12.9.3 Biodefense Sales, Revenue, Price and Gross Margin of DynPort Vaccine
12.10 Xoma Corporation
12.10.1 Company profile
12.10.2 Representative Biodefense Product
12.10.3 Biodefense Sales, Revenue, Price and Gross Margin of Xoma Corporation
12.11 Ichor Medical Systems
12.11.1 Company profile
12.11.2 Representative Biodefense Product
12.11.3 Biodefense Sales, Revenue, Price and Gross Margin of Ichor Medical Systems
12.12 Aeolus Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Biodefense Product
12.12.3 Biodefense Sales, Revenue, Price and Gross Margin of Aeolus Pharmaceuticals
12.13 Achaogen
12.13.1 Company profile
12.13.2 Representative Biodefense Product
12.13.3 Biodefense Sales, Revenue, Price and Gross Margin of Achaogen
12.14 Elusys Therapeutics
12.14.1 Company profile
12.14.2 Representative Biodefense Product
12.14.3 Biodefense Sales, Revenue, Price and Gross Margin of Elusys Therapeutics
12.15 Dynavax Technologies
12.15.1 Company profile
12.15.2 Representative Biodefense Product
12.15.3 Biodefense Sales, Revenue, Price and Gross Margin of Dynavax Technologies
12.16 Cleveland BioLabs
12.17 Soligenix
12.18 Alnylam Pharmaceuticals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIODEFENSE
13.1 Industry Chain of Biodefense
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BIODEFENSE
14.1 Cost Structure Analysis of Biodefense
14.2 Raw Materials Cost Analysis of Biodefense
14.3 Labor Cost Analysis of Biodefense
14.4 Manufacturing Expenses Analysis of Biodefense
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Biodefense in This Report
1.2 Commercial Types of Biodefense
1.2.1 Anthrax
1.2.2 Smallpox
1.2.3 Botulism
1.2.4 Radiation/Nuclear
1.3 Downstream Application of Biodefense
1.3.1 Industry
1.3.2 Chemical
1.4 Development History of Biodefense
1.5 Market Status and Trend of Biodefense 2013-2023
1.5.1 Global Biodefense Market Status and Trend 2013-2023
1.5.2 Regional Biodefense Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biodefense 2013-2017
2.2 Sales Market of Biodefense by Regions
2.2.1 Sales Volume of Biodefense by Regions
2.2.2 Sales Value of Biodefense by Regions
2.3 Production Market of Biodefense by Regions
2.4 Global Market Forecast of Biodefense 2018-2023
2.4.1 Global Market Forecast of Biodefense 2018-2023
2.4.2 Market Forecast of Biodefense by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Biodefense by Types
3.2 Sales Value of Biodefense by Types
3.3 Market Forecast of Biodefense by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Biodefense by Downstream Industry
4.2 Global Market Forecast of Biodefense by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Biodefense Market Status by Countries
5.1.1 North America Biodefense Sales by Countries (2013-2017)
5.1.2 North America Biodefense Revenue by Countries (2013-2017)
5.1.3 United States Biodefense Market Status (2013-2017)
5.1.4 Canada Biodefense Market Status (2013-2017)
5.1.5 Mexico Biodefense Market Status (2013-2017)
5.2 North America Biodefense Market Status by Manufacturers
5.3 North America Biodefense Market Status by Type (2013-2017)
5.3.1 North America Biodefense Sales by Type (2013-2017)
5.3.2 North America Biodefense Revenue by Type (2013-2017)
5.4 North America Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Biodefense Market Status by Countries
6.1.1 Europe Biodefense Sales by Countries (2013-2017)
6.1.2 Europe Biodefense Revenue by Countries (2013-2017)
6.1.3 Germany Biodefense Market Status (2013-2017)
6.1.4 UK Biodefense Market Status (2013-2017)
6.1.5 France Biodefense Market Status (2013-2017)
6.1.6 Italy Biodefense Market Status (2013-2017)
6.1.7 Russia Biodefense Market Status (2013-2017)
6.1.8 Spain Biodefense Market Status (2013-2017)
6.1.9 Benelux Biodefense Market Status (2013-2017)
6.2 Europe Biodefense Market Status by Manufacturers
6.3 Europe Biodefense Market Status by Type (2013-2017)
6.3.1 Europe Biodefense Sales by Type (2013-2017)
6.3.2 Europe Biodefense Revenue by Type (2013-2017)
6.4 Europe Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Biodefense Market Status by Countries
7.1.1 Asia Pacific Biodefense Sales by Countries (2013-2017)
7.1.2 Asia Pacific Biodefense Revenue by Countries (2013-2017)
7.1.3 China Biodefense Market Status (2013-2017)
7.1.4 Japan Biodefense Market Status (2013-2017)
7.1.5 India Biodefense Market Status (2013-2017)
7.1.6 Southeast Asia Biodefense Market Status (2013-2017)
7.1.7 Australia Biodefense Market Status (2013-2017)
7.2 Asia Pacific Biodefense Market Status by Manufacturers
7.3 Asia Pacific Biodefense Market Status by Type (2013-2017)
7.3.1 Asia Pacific Biodefense Sales by Type (2013-2017)
7.3.2 Asia Pacific Biodefense Revenue by Type (2013-2017)
7.4 Asia Pacific Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Biodefense Market Status by Countries
8.1.1 Latin America Biodefense Sales by Countries (2013-2017)
8.1.2 Latin America Biodefense Revenue by Countries (2013-2017)
8.1.3 Brazil Biodefense Market Status (2013-2017)
8.1.4 Argentina Biodefense Market Status (2013-2017)
8.1.5 Colombia Biodefense Market Status (2013-2017)
8.2 Latin America Biodefense Market Status by Manufacturers
8.3 Latin America Biodefense Market Status by Type (2013-2017)
8.3.1 Latin America Biodefense Sales by Type (2013-2017)
8.3.2 Latin America Biodefense Revenue by Type (2013-2017)
8.4 Latin America Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Biodefense Market Status by Countries
9.1.1 Middle East and Africa Biodefense Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Biodefense Revenue by Countries (2013-2017)
9.1.3 Middle East Biodefense Market Status (2013-2017)
9.1.4 Africa Biodefense Market Status (2013-2017)
9.2 Middle East and Africa Biodefense Market Status by Manufacturers
9.3 Middle East and Africa Biodefense Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Biodefense Sales by Type (2013-2017)
9.3.2 Middle East and Africa Biodefense Revenue by Type (2013-2017)
9.4 Middle East and Africa Biodefense Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BIODEFENSE
10.1 Global Economy Situation and Trend Overview
10.2 Biodefense Downstream Industry Situation and Trend Overview
CHAPTER 11 BIODEFENSE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Biodefense by Major Manufacturers
11.2 Production Value of Biodefense by Major Manufacturers
11.3 Basic Information of Biodefense by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Biodefense Major Manufacturer
11.3.2 Employees and Revenue Level of Biodefense Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BIODEFENSE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Emergent Biosolutions
12.1.1 Company profile
12.1.2 Representative Biodefense Product
12.1.3 Biodefense Sales, Revenue, Price and Gross Margin of Emergent Biosolutions
12.2 Hytest
12.2.1 Company profile
12.2.2 Representative Biodefense Product
12.2.3 Biodefense Sales, Revenue, Price and Gross Margin of Hytest
12.3 GSK
12.3.1 Company profile
12.3.2 Representative Biodefense Product
12.3.3 Biodefense Sales, Revenue, Price and Gross Margin of GSK
12.4 Sanofi
12.4.1 Company profile
12.4.2 Representative Biodefense Product
12.4.3 Biodefense Sales, Revenue, Price and Gross Margin of Sanofi
12.5 PharmAthene
12.5.1 Company profile
12.5.2 Representative Biodefense Product
12.5.3 Biodefense Sales, Revenue, Price and Gross Margin of PharmAthene
12.6 Bavarian Nordic
12.6.1 Company profile
12.6.2 Representative Biodefense Product
12.6.3 Biodefense Sales, Revenue, Price and Gross Margin of Bavarian Nordic
12.7 SIGA Technologies
12.7.1 Company profile
12.7.2 Representative Biodefense Product
12.7.3 Biodefense Sales, Revenue, Price and Gross Margin of SIGA Technologies
12.8 Arbutus Biopharma
12.8.1 Company profile
12.8.2 Representative Biodefense Product
12.8.3 Biodefense Sales, Revenue, Price and Gross Margin of Arbutus Biopharma
12.9 DynPort Vaccine
12.9.1 Company profile
12.9.2 Representative Biodefense Product
12.9.3 Biodefense Sales, Revenue, Price and Gross Margin of DynPort Vaccine
12.10 Xoma Corporation
12.10.1 Company profile
12.10.2 Representative Biodefense Product
12.10.3 Biodefense Sales, Revenue, Price and Gross Margin of Xoma Corporation
12.11 Ichor Medical Systems
12.11.1 Company profile
12.11.2 Representative Biodefense Product
12.11.3 Biodefense Sales, Revenue, Price and Gross Margin of Ichor Medical Systems
12.12 Aeolus Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Biodefense Product
12.12.3 Biodefense Sales, Revenue, Price and Gross Margin of Aeolus Pharmaceuticals
12.13 Achaogen
12.13.1 Company profile
12.13.2 Representative Biodefense Product
12.13.3 Biodefense Sales, Revenue, Price and Gross Margin of Achaogen
12.14 Elusys Therapeutics
12.14.1 Company profile
12.14.2 Representative Biodefense Product
12.14.3 Biodefense Sales, Revenue, Price and Gross Margin of Elusys Therapeutics
12.15 Dynavax Technologies
12.15.1 Company profile
12.15.2 Representative Biodefense Product
12.15.3 Biodefense Sales, Revenue, Price and Gross Margin of Dynavax Technologies
12.16 Cleveland BioLabs
12.17 Soligenix
12.18 Alnylam Pharmaceuticals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIODEFENSE
13.1 Industry Chain of Biodefense
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BIODEFENSE
14.1 Cost Structure Analysis of Biodefense
14.2 Raw Materials Cost Analysis of Biodefense
14.3 Labor Cost Analysis of Biodefense
14.4 Manufacturing Expenses Analysis of Biodefense
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
